Page last updated: 2024-11-02

oxyphenbutazone and Eosinophilic Granuloma

oxyphenbutazone has been researched along with Eosinophilic Granuloma in 1 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Eosinophilic Granuloma: The most benign and common form of Langerhans-cell histiocytosis which involves localized nodular lesions predominantly of the bones but also of the gastric mucosa, small intestine, lungs, or skin, with infiltration by EOSINOPHILS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Enokihara, H1
Saito, K1
Hazama, S1
Hirose, K1
Komatsu, H1
Furusawa, S1
Shishido, H1

Other Studies

1 other study available for oxyphenbutazone and Eosinophilic Granuloma

ArticleYear
[A case of soft tissue eosinophilic granuloma (author's transl)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1978, Volume: 19, Issue:4

    Topics: Adult; Eosinophilic Granuloma; Humans; Male; Oxyphenbutazone

1978